Intracranial self-stimulation of the paraventricular nucleus of the hypothalamus: Increased faciliation by morphine compared to cocaine

Anesthesiology

Volumn 116, Issue 5, 2012, Pages 1116-1122

  Ewan, Eric E ^a   Martin, Thomas J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FACILITATION; HYPOTHALAMUS; INTRACRANIAL SELF STIMULATION; MALE; MEDIAL FOREBRAIN BUNDLE; NERVE INJURY; NERVE STIMULATION; NEUROMODULATION; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PARAVENTRICULAR THALAMIC NUCLEUS; PAW WITHDRAWAL THRESHOLD; PRIORITY JOURNAL; RAT; REWARD; SELF STIMULATION; VENTRAL TEGMENTUM;

ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANIMALS; COCAINE; DATA INTERPRETATION, STATISTICAL; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; HYPERALGESIA; LIGATION; MALE; MORPHINE; PAIN MEASUREMENT; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, INBRED F344; SELF STIMULATION; SPINAL NERVES;

EID: 84860777236     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182518be3     Document Type: Article

References (23)

1. Carlezon WA Jr, Chartoff EH: Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2007; 2:2987-95
2. Wise RA: Addictive drugs and brain stimulation reward. Annu Rev Neurosci 1996; 19:319-40
3. Ewan EE, Martin TJ: Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain. ANESTHESIOLOGY 2011; 114:624-32
4. Ewan EE, Martin TJ: Rewarding electrical brain stimulation in rats after peripheral nerve injury: Decreased facilitation by commonly abused prescription opioids. ANESTHESIOLOGY 2011; 115: 1271-80
5. Baskerville TA, Douglas AJ: Dopamine and oxytocin interactions underlying behaviors: Potential contributions to behavioral disorders. CNS Neurosci Ther 2010; 16:e92-123
6. Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, Ueta Y, Zingg HH, Chvatal A, Sykova E, Dayanithi G: REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther 2010; 16: e138-56
7. Sarnyai Z: Oxytocin as a potential mediator and modulator of drug addiction. Addict Biol 2011; 16:199-201
8. Melis MR, Melis T, Cocco C, Succu S, Sanna F, Pillolla G, Boi A, Ferri GL, Argiolas A: Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats. Eur J Neurosci 2007; 26:1026-35
9. Vaccari C, Lolait SJ, Ostrowski NL: Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 1998; 139:5015-33
10. Kovcs GL, Borthaiser Z, Telegdy G: Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats. Life Sci 1985; 37:17-26
11. Kovcs GL, Sarnyai Z, Izbki F, Szab G, Telegdy G, Barth T, Jost K, Brtnik F: Effects of oxytocin-related peptides on acute morphine tolerance: Opposite actions by oxytocin and its receptor antagonists. J Pharmacol Exp Ther 1987; 241: 569-74
12. Ibragimov R, Kovcs GL, Szab G, Telegdy G: Microinjection of oxytocin into limbic-mesolimbic brain structures disrupts heroin self-administration behavior: A receptor-mediated event? Life Sci 1987; 41:1265-71
13. Sarnyai Z, Babarczy E, Krivn M, Szab G, Kovcs GL, Barth T, Telegdy G: Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: Putative role of basal forebrain target sites. Neuropeptides 1991; 19:51-6
14. Martin TJ, Kim SA, Buechler NL, Porreca F, Eisenach JC: Opioid self-administration in the nerve-injured rat: Relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. ANESTHESIOLOGY 2007; 106:312-22
15. Nichols ML, Bian D, Ossipov MH, Lai J, Porreca F: Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J Pharmacol Exp Ther 1995; 275:1339-45
16. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63
17. Pierce RC, Kumaresan V: The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 2006; 30:215-38
18. Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85:5274-8
19. Niikura K, Narita M, Butelman ER, Kreek MJ, Suzuki T: Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. Trends Pharmacol Sci 2010; 31:299-305
20. Gysling K, Wang RY: Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res 1983; 277:119-27
21. Martnez-Lorenzana G, Espinosa-Lpez L, Carranza M, Aramburo C, Paz-Tres C, Rojas-Piloni G, Conds-Lara M: PVN electrical stimulation prolongs withdrawal latencies and releases oxytocin in cerebrospinal fluid, plasma, and spinal cord tissue in intact and neuropathic rats. Pain 2008; 140: 265-73
22. Miranda-Cardenas Y, Rojas-Piloni G, Martnez-Lorenzana G, Rodrguez-Jimnez J, Lpez-Hidalgo M, Freund-Mercier MJ, Conds-Lara M: Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist. Pain 2006; 122:182-9
23. Paxinos G, Watson C: The rat brain in stereotaxic coordinates. New York, NY, Academic Press, 1998